Companies / Turkey
Eczacibasi Considers Divestment
December 2006 | Company Finance AlertTurkish industrial group Eczacibasi is reported to be considering divesting a 50% stake in its generic drug unit. According to industry sources, the whole division is valued at around US$650mn. In 2005, generic drug sales contributed around US$250mn to Eczacibasi Pharmaceuticals total revenues of US$811mn.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.




